Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2023;13(3): 512-520. doi: 10.34172/apb.2023.062
PMID: 37646057        PMCID: PMC10460802

Mini Review

Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors

Soheil Mehrdadi 1 * ORCID

Cited by CrossRef: 9

1- Bao X, Zheng Z, Li M, Wang X, Zhao Q, Wang H, Xin Y, Jiang X. Enhancing the sensitivity of radiotherapy in non-small cell lung cancer through nanotechnology-mediated reactive oxygen species generation. Coordination Chemistry Reviews. 2026;549:217234 [Crossref]
2- Khamis W, Hussein H, Hilaly Y, Hilaly D. The Eco‐Friendly Preparation of Se, Zn, and Ag MONPs and Their Current Medical Applications and Drug Delivery for AD Diseases. The Scientific World Journal. 2026;2026(1) [Crossref]
3- Grzegorzewski J, Michalak M, Wołoszczuk M, Bulicz M, Majchrzak-Celińska A. Nanotherapy of Glioblastoma—Where Hope Grows. IJMS. 2025;26(5):1814 [Crossref]
4- Arafat M, Sakkal M, Beiram R, AbuRuz S. Nanomedicines: Emerging Platforms in Smart Chemotherapy Treatment—A Recent Review. Pharmaceuticals. 2024;17(3):315 [Crossref]
5- Mahendran G, Shangaradas A, Romero-Moreno R, Wickramarachchige Dona N, Sarasija S, Perera S, Silva G. Unlocking the epigenetic code: new insights into triple-negative breast cancer. Front Oncol. 2024;14 [Crossref]
6- Lim H, Seo Y, Min S, Yoo D, Heo D, Kwon I, Lee T. Construction of Chitosan Oligosaccharide-Coated Nanostructured Lipid Carriers for the Sustained Release of Strontium Ranelate. Tissue Eng Regen Med. 2025;22(4):425 [Crossref]
7- Dhingra P, Das Gupta G, Kumar A, Patel P, Das Kurmi B. Glioblastoma IDH-wildtype: An integrative review of pathophysiological mechanisms, diagnostic innovations, and emerging therapeutic modalities. Pathology - Research and Practice. 2026;282:156471 [Crossref]
8- Zheng Y, Cui L, Lu H, Liu Z, Zhai Z, Wang H, Shao L, Lu Z, Song X, Zhang Y. Nose to Brain: Exploring the Progress of Intranasal Delivery of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers. IJN. 2024;Volume 19:12343 [Crossref]
9- Davari M, Salarizadeh N, Hushmandi K, Gouvarchin ghaleh H, Asoodeh A, Nazarpour V. Advances in nucleic acid delivery using nanocarriers for gene therapy in cancer: A narrative review. Critical Reviews in Oncology/Hematology. 2026;223:105367 [Crossref]
10- Zhang H, Shi K, Zhang W, Chen X, Wang X, Zhao Y, Pang H, Chen X, Wang J. A novel strategy for the photothermal treatment and electroencephalogram monitoring of in situ glioma. RSC Adv. 2026;16(32):28955 [Crossref]
11- Tanaka M, Araujo A, Valenti V, Guiguer E, Catharin V, Gualhardi C, de Souza Bastos Mazuqueli Pereira E, de Alvares Goulart R, de Argolo Haber R, de Carvalho A, Barbalho S. From Polyphenols to Prodrugs: Bridging the Blood–Brain Barrier with Nanomedicine and Neurotherapeutics. IJMS. 2026;27(5):2370 [Crossref]
12- Gouveia M, Vale N. From Therapeutic Drug to Xenobiotic in Cancer Repurposing: Clozapine Mechanisms, Metabolic Liabilities, and Human-Relevant Translational Approaches. JoX. 2026;16(4):125 [Crossref]
13- Mesut B, Al-Mohaya M, Gholap A, Yeşilkaya E, Das U, Akhtar M, Sah R, Khan S, Moin A, Faiyazuddin M. Demystifying the potential of lipid-based nanocarriers in targeting brain malignancies. Naunyn-Schmiedeberg's Arch Pharmacol. 2024;397(12):9243 [Crossref]
14- Li J, Basu K, Chen X, Li T. Manifold Embedding of Quantum Information as Molecule Representation to Predict Blood-Brain Barrier Permeability by Deep Learning. Mol Pharmaceutics. 2025;22(11):7087 [Crossref]
15- Hu G, Wang L, Fan L, Sun J, He D. Photodynamic therapy for oral mucosal lesions: photosensitizer evolution, pharmacological mechanisms, and clinical translation. Front Pharmacol. 2026;17 [Crossref]
16- Hashmi A, Zahra F, Sekar M, Al Hamod M, Al Hamood N, Begum M, Molugulu N, Wong L, Kumarasamy V. SmartLipids in Drug Delivery: Redefining the Third Generation of Lipid Nanocarriers for Clinical and Industrial Translation. IJN. 2026;Volume 21:1 [Crossref]
17- Abu-Hdaib B, Nsairat H, El-Tanani M, Al-Deeb I, Hasasna N. In vivo evaluation of mebendazole and Ran GTPase inhibition in breast cancer model system . Nanomedicine. 2024;19(12):1087 [Crossref]
18- Xu C, Zhao Y, Yang X, Zheng J, Tang Q. Exploration of current situation of psychotropic drugs research and development in China based on drug clinical trials. Front Psychiatry. 2025;16 [Crossref]
19- Gao X, Ciura K, Ma Y, Mikolajczyk A, Jagiello K, Wan Y, Gao Y, Zheng J, Zhong S, Puzyn T, Gao X. Toward the Integration of Machine Learning and Molecular Modeling for Designing Drug Delivery Nanocarriers. Advanced Materials. 2024;36(45) [Crossref]
20- Vinchurkar R, Kuchekar A. Design, optimization, and evaluation of ferulic acid-loaded cubosomal cream for enhanced topical delivery and anti-hyperpigmentation efficacy. Drug Development and Industrial Pharmacy. 2026;:1 [Crossref]
21- Jacob S, Rao R, Gorain B, Boddu S, Nair A. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Anticancer Phytochemical Delivery: Advances, Challenges, and Future Prospects. Pharmaceutics. 2025;17(8):1079 [Crossref]
22- Jawad M, Shafique U, Din F, Butt A, Khan S, Khan G, Alamri A, Lahiq A, Alsharif S, Almerai K. Nose to brain delivery of escitalopram-loaded nano-structured lipid carriers thermosensitive gel: Formulation, physiochemical, pharmacokinetic and pharmacodynamics evaluation. Journal of Drug Delivery Science and Technology. 2024;97:105800 [Crossref]
23- Riccobelli P, Pierce B, Craparo E, Bonini S, Pasut G, Fanzani A, Mandracchia D. Advances in Nanoparticle Systems for Targeted Therapy against Glioblastoma Multiforme. International Journal of Pharmaceutics. 2025;682:125969 [Crossref]
24- Peng X, Ma Y, Yan C, Wei X, Zhang L, Jiang H, Ma Y, Zhang S, Xing M, Gao Y. Mechanism, Formulation, and Efficacy Evaluation of Natural Products for Skin Pigmentation Treatment. Pharmaceutics. 2024;16(8):1022 [Crossref]
25- Wang H, Bo W, Feng X, Zhang J, Li G, Chen Y. Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System. IJN. 2024;Volume 19:5581 [Crossref]
26- Hafeez A. Recent Advancements in the Chitosan‐Decorated Nasal Drug Delivery Systems: Biopharmaceutical Characteristics, Patent Reports, and Clinical Trials. Starch Stärke. 2026;78(7) [Crossref]
27- Kadhim S, Dehghan G, Mahdavi M. Ciprofloxacin-encapsulated solid lipid nanoparticles: a comprehensive biochemical analysis of cytotoxic effects, proliferation inhibition, and apoptotic induction in KG1-a leukemia cells. Med Oncol. 2025;42(3) [Crossref]
28- Li H, Guan M, Zhang N, Wang Y, Liang T, Wu H, Wang C, Sun T, Liu S. Harnessing nanomedicine for modulating microglial states in the central nervous system disorders: Challenges and opportunities. Biomedicine & Pharmacotherapy. 2024;177:117011 [Crossref]